Derek Burkhard and Mike Ramirez discuss notable big pharma full-year 2019 presentations.
Topics covered in this episode include:
• Overall company performance of Merck, Roche, AstraZeneca, Gilead, Sanofi, and GlaxoSmithKline (1:00)
• Current spin-offs & rationale (20:49)
• Discussion on notable big pharma M&A deals, and companies that may be looking to engage in M&A in the near future (27:49)
• China revenues, growth, and the potential impact of COVID-19 (36:42)
To learn more about Datamonitor Healthcare, Biomedtracker, and other offerings from Pharma Intelligence, visit:
pharmaintelligence.informa.com/
